Disease-linked variants speed age-related signaling changes in worms
Worms with disease-linked human protein variants became unusually sensitive to a signaling-test drug by adult day 5, versus between days 5 and 9 in controls.
Our read
Mechanisms- Studied:
- Experiments in genetically modified Caenorhabditis elegans worms, against control worms
- What changed:
- Drug hypersensitivity appeared by day 5 in worms expressing disease-linked variants, versus between days 5 and 9 in controls
- The catch:
- Assessors knew which worms they examined, risking bias in drug-sensitivity measurements
- In the record:
- One of 51 papers on HSPB1 on record: 3 with results in people, 4 in animals.
- Why it’s aging research:
- It looks at how biology varies with age or lifespan.
Editor of record: Boris Djordjevic · AgingResearch.News
Caenorhabditis elegans worms genetically modified to make human HSPB1 in nerve cells were studied in an animal experiment. HSPB1 is a protein that helps other proteins fold. Researchers compared the normal protein with three variants linked to Charcot-Marie-Tooth disease, assessing worms on adult days 1, 5 and 9.
All three variants caused an early defect in nerve-to-muscle signaling, measured by sensitivity to the drug aldicarb. They also accelerated age-related changes in this sensitivity: worms expressing the variants became hypersensitive by day 5, while controls shifted between days 5 and 9. Worms making normal human HSPB1 did not undergo this shift over the ages tested. Tests with another drug suggested the variants affected the nerve side of the connection rather than the muscle’s response to nerve signals.
Why it matters
Charcot-Marie-Tooth disease causes progressive muscle weakness. The authors suggest a possible mechanism for how HSPB1 variants produce nerve-to-muscle signaling defects that worsen over time.
Caveats
Signaling was assessed through drug sensitivity, and assessors knew which worms they were examining. These were genetically modified worms, not people with Charcot-Marie-Tooth disease.
- HSPB1
- Proteostasis
- Synaptic transmission
- Charcot-Marie-Tooth disease type 2
- Aldicarb sensitivity
- C. elegans
The paper
Charcot-Marie-Tooth disease variants of HSPB1 progressively alter neuromuscular signalling
University of Liverpool
Disease Models & Mechanisms, Jul 23, 2026, Open access
Comments
Be the first to comment.